Search Results - "Echarri, M J"

Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience by Pérez Ramírez, S., del Monte-Millán, M., López-Tarruella, S., Martínez Jáñez, N., Márquez-Rodas, I., Lobo Samper, F., Izarzugaza Perón, Y., Rubio Terres, C., Rubio Rodríguez, D., García-Sáenz, J. Á., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M. Á., Ciruelos Gil, E. M., Manso Sánchez, L., Echarri González, M. J., Guerra Martínez, J. A., Jara Sánchez, C., Bueno Muiño, C., García Adrián, S., Carrión Galindo, J. R., Valentín Maganto, V., Martín, M.

“…Introduction The aim of this study is to evaluate the cost-effectiveness and impact of gene-expression assays (GEAs) on treatment decisions in a real-world…”
Get full text

A non-cooperative mechanism for the Shapley value of airport problems by Albizuri, M. J., Echarri, J. M., Zarzuelo, J. M.

“…In this paper we address the question of how to allocate the total cost of building and maintaining an airport runway among its users based on a…”
Get full text

A Non-cooperative Mechanism Yielding the Nucleolus of Airport Problems by Albizuri, M. J., Echarri, J. M., Zarzuelo, J. M.

“…A non-cooperative approach is employed to solve the problem of allocating the total cost of building and maintaining an airport runway among its users. More…”
Get full text

Use of bevacizumab as a first-line treatment for metastatic breast cancer by Manso, L, Moreno, F, Márquez, R, Castelo, B, Arcediano, A, Arroyo, M, Ballesteros, A I, Calvo, I, Echarri, M J, Enrech, S, Gómez, A, González Del Val, R, López-Miranda, E, Martín-Angulo, M, Martínez-Jañez, N, Olier, C, Zamora, P

“…During clinical practice, it can be challenging, given the lack of response biomarkers, to identify the patients with metastatic breast cancer (mbca) who would…”
Get full text

Torsion points on the jacobian of a Fermat quotient by Clement Fernández, R., Echarri Hernández, J.M., Gómez Ayala, E.J.

“…Let p ≥ 5 be a prime, ζ a primitive p th root of unity and λ = 1 − ζ . For 1 ≤ s ≤ p − 2 , the smooth projective model C p , s of the affine curve v p = u s (…”
Get full text

High reduction of circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin) by Manso, L., Moreno, F., Delgado, J.I., Echarri, M.J., López, A., Izarzugaza, Y., Borrega, P., Martínez, N., Olier, C., Cortes-Funes, H.

Get full text

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication by Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.

“…The phase III CLinical Evaluation Of Pertuzumab And TRAstuzumab (CLEOPATRA) trial established the combination of pertuzumab, trastuzumab and docetaxel as…”
Get full text

Abstract P6-07-21: High reduction of circulating tumour cells in HER2-negative locally advanced or metastatic breast cancer (LAMBC) patients treated with eribulin as third line chemotherapy (ONSITE study) by Manso Sánchez, L, Moreno Antón, F, Izarzugaza Perón, Y, Delgado Mingorance, I, Borrega García, P, Echarri González, MJ, Martínez Jáñez, N, López González, A, Olier Garate, C, Ballesteros García, A, Chacón López-Muñiz, I, Ciruelos Gil, EM, García Sáenz, JA, Paz-Ares Rodríguez, L

“…Background Circulating tumour cells (CTC) may be a good biomarker to guide the management of patients with LAMBC (Cristofanilli, NEJM 2004). Detection of CTCs…”
Get full text